Global Coalition on Aging Reaffirms Commitment to a Life Course Approach to Immunization on World Pneumonia Day

NEW YORK (November 12, 2015) – As part of its ongoing commitment to healthy and active aging, the Global Coalition on Aging (GCOA) is proud to raise awareness of World Pneumonia Day, draw attention to pneumonia’s continued prevalence in communities around the world, and promote the importance of immunization as a core strategy for prevention and wellness across the life course.

Despite major scientific advances, pneumonia – a life-threatening respiratory infection – remains a serious threat to both children and adults globally and is one of the leading causes of death worldwide. In children five years and under, pneumococcal disease causes roughly a million deaths annually, according to the World Health Organization.

With a billion people over 50 today, pneumonia is also a huge health challenge for older adults who are more likely to have compromised immune systems.

“As our population ages, pneumonia will only surge as a global threat across developed and developing countries alike,” said Michael Hodin, Chief Executive Officer of GCOA. “The good news is that pneumonia can be prevented, and in fact millions of children have been protected through these life-saving vaccinations. Unfortunately, this fundamental piece of children’s healthcare strategy around the world has yet to extend to adults in our era of longevity.”

GCOA advocates for a “life course approach to immunization.” In its 2013 report on the topic, GCOA underscored the need for a greater awareness of the role of vaccines as a preventive measure as the global population ages, highlighting that immunizations among adults remain below target levels. The result is unnecessary costs, unwanted health outcomes, and poor utilization of health resources.

Today, there are roughly 900,000 annual cases of pneumococcal pneumonia in the United States and about 400,000 hospitalizations each year, according to the Centers for Disease Control and Prevention. World Pneumonia Day aims to highlight the importance of interventions and encourage action so that the impact on individuals, families and health systems can be prevented.

“An emphasis on adult immunization will not only improve the health of the aging population but will also alleviate burdens on families, communities and healthcare systems,” said Hodin. “As part of the global public health community, we have a responsibility to help improve society through education on important measures for prevention and wellness. We are delighted to work with our members to raise awareness on this important day.”

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.